In-depth understanding of PTMs on SLC7A11 and GPX4 will certainly shed new insight into the biology of ferroptosis in pathogenesis and therapy response of HCC and more importantly inspire SLC7A11- and GPX4- based combinatorial therapeutic regimens with improved clinical efficacy. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.